[
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=7500e89fc11a3aba7de02c09f0886ea5fb5339b002479f5b457f539f45c2e43b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755793980,
      "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "id": 136489243,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=7500e89fc11a3aba7de02c09f0886ea5fb5339b002479f5b457f539f45c2e43b"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at approximately USD 478.83 Billion in 2024 and is expected to reach USD 527.36 Billion in 2025 and is expected to reach around USD 1,320.19 Billion by 2034, at a CAGR of 10.42% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Amgen Inc., P",
    "url": "https://finnhub.io/api/news?id=9aaef2be70e1f2d712f1b47c8b1dce64987548f13e4fff641e2d6a7b53569d78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755793800,
      "headline": "[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136467561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at approximately USD 478.83 Billion in 2024 and is expected to reach USD 527.36 Billion in 2025 and is expected to reach around USD 1,320.19 Billion by 2034, at a CAGR of 10.42% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Amgen Inc., P",
      "url": "https://finnhub.io/api/news?id=9aaef2be70e1f2d712f1b47c8b1dce64987548f13e4fff641e2d6a7b53569d78"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=09db6a555a26bd91ca0578e05f38589eff6be6698c5cb930ddfdf166b0c6c701",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755781205,
      "headline": "Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 136467700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=09db6a555a26bd91ca0578e05f38589eff6be6698c5cb930ddfdf166b0c6c701"
    }
  },
  {
    "ts": null,
    "headline": "Leaders Come Together to Advance the Industry at Veeva Summit",
    "summary": "Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne Medicines, Intercept Pharmaceuticals, Merck, and Pfizer are among the leaders coming together September 3-4 in Boston to share how they are advancing clinical, regulatory, safety, and quality.",
    "url": "https://finnhub.io/api/news?id=26a468193de7bd021b5caf35fcf05380c75519b7984d369a471a769d51208da7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755774180,
      "headline": "Leaders Come Together to Advance the Industry at Veeva Summit",
      "id": 136452617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne Medicines, Intercept Pharmaceuticals, Merck, and Pfizer are among the leaders coming together September 3-4 in Boston to share how they are advancing clinical, regulatory, safety, and quality.",
      "url": "https://finnhub.io/api/news?id=26a468193de7bd021b5caf35fcf05380c75519b7984d369a471a769d51208da7"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q2 2025 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) outperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=f8b7703fb46da00d8ea965f9f056688fcf2528cb789b78bb6f1c7c7ea46efb79",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755771900,
      "headline": "Hartford Healthcare Fund Q2 2025 Commentary",
      "id": 136458913,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/685006799/image_685006799.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) outperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=f8b7703fb46da00d8ea965f9f056688fcf2528cb789b78bb6f1c7c7ea46efb79"
    }
  },
  {
    "ts": null,
    "headline": "The biggest Big Pharma losers in the first half of 2025",
    "summary": "What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.",
    "url": "https://finnhub.io/api/news?id=9cb565fe7f5519741b3a7c473e899e4980e959a1ae73b94892745f59c839b897",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755769203,
      "headline": "The biggest Big Pharma losers in the first half of 2025",
      "id": 136467565,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.",
      "url": "https://finnhub.io/api/news?id=9cb565fe7f5519741b3a7c473e899e4980e959a1ae73b94892745f59c839b897"
    }
  }
]